ArticleACS medicinal chemistry letters2015

Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.

Shawn P Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.